Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review

JAMA Health Forum. 2022 Dec 2;3(12):e224631. doi: 10.1001/jamahealthforum.2022.4631.
No abstract available

Plain language summary

This cross-sectional study estimates how annual US drug spending would change if prices for prescription drugs were set at the value-based price.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Costs and Cost Analysis
  • Drug Costs
  • Income
  • Prescription Drugs*


  • Prescription Drugs